65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79722D0166
Awardee
Awarding agency
Task orders
1

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 85% complete
IDV ceiling
$59,852,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a Federal Supply Schedule contract to Ascendis Pharma, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on July 15, 2022, with a contract ceiling of $59.8 million and performance through July 14, 2027.

The contract covers drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. No set-aside applies. Place of performance is nationwide through the VA's supply network.

Recent ordering activity includes a delivery order issued July 15, 2025, to Veterans Integrated Service Network 20 for Yorvipath 168 mcg injection solution pen valued at $210,117.92, with delivery to a VA facility in Pittsburgh, Pennsylvania. The delivery was completed by July 14, 2026. Yorvipath addresses growth hormone deficiency in veterans.

Ascendis Pharma is a foreign-owned pharmaceutical company specializing in rare disease treatments. The company maintains a complementary single-award Blanket Purchase Agreement under the same FSS schedule with a ceiling of $18 million, with an ultimate completion date of July 2, 2026. The Federal Supply Schedule contract enables the VA to procure critical pharmaceutical products through streamlined ordering mechanisms to support specialized medical treatment needs across the veterans healthcare system.

Task orders

Task order Ordering agency Obligated Awarded
Yorvipath 168MCG INJ, soln, pen 36C26025F0329 Veterans Integrated Service Network 20 (VHA) $210,118

IDV awards

IDV Agency Ceiling Awarded
36E79725A0003 BPA for yorvipath National Acquisition Center (VA) $18,000,000

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00022 $0
Supplemental Agreement for work within scope P00021 $0
Supplemental Agreement for work within scope P00017 $0
Other Administrative Action P00020 $0
Supplemental Agreement for work within scope P00019 $0
Other Administrative Action P00018 $0
Other Administrative Action P00016 $0
Supplemental Agreement for work within scope P00015 · FSS $0
Supplemental Agreement for work within scope P00014 · PL 2026 price updates $0
Other Administrative Action P00013 $0
Supplemental Agreement for work within scope P00011 $0
Other Administrative Action P00012 $0
Other Administrative Action P00010 · FSS $0
Supplemental Agreement for work within scope P00009 · 65IB, 42-2A product addition - provisional federal ceiling price (FCP) - single pricing $0
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00008 $0
Other Administrative Action P00006 · FSS $0
Supplemental Agreement for work within scope P00005 · PL update $0
Other Administrative Action P00004 · FSS $0
Supplemental Agreement for work within scope P00003 · Public law 2023 pricing updates. $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 · FSS $0
Original award $0
Show all 23

Quick answers

Who was awarded contract 36F79722D0166?

36F79722D0166 was awarded to Ascendis Pharma, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 15, 2022.

How much is contract 36F79722D0166 worth?

36F79722D0166's own ceiling is $59,852,000.

How many orders have been placed under contract 36F79722D0166?

1 order has been placed under 36F79722D0166, the latest on July 15, 2025.

Who can order from contract 36F79722D0166?

36F79722D0166 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79722D0166 part of a contract vehicle?

Yes. 36F79722D0166 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79722D0166 competed?

The extent of competition for 36F79722D0166 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV